- Home
- CEAD vs ALLR Comparison
CEAD vs ALLR Comparison
Compare CEAD & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- ALLR
- Stock Information
- Founded
- CEAD 2009
- ALLR 2004
- Country
- CEAD United States
- ALLR United States
- Employees
- CEAD N/A
- ALLR N/A
- Industry
- CEAD Industrial Machinery/Components
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- CEAD Industrials
- ALLR Health Care
- Exchange
- CEAD Nasdaq
- ALLR Nasdaq
- Market Cap
- CEAD 6.4M
- ALLR 6.0M
- IPO Year
- CEAD N/A
- ALLR N/A
- Fundamental
- Price
- CEAD $7.23
- ALLR $1.03
- Analyst Decision
- CEAD
- ALLR
- Analyst Count
- CEAD 0
- ALLR 0
- Target Price
- CEAD N/A
- ALLR N/A
- AVG Volume (30 Days)
- CEAD 5.8K
- ALLR 3.8M
- Earning Date
- CEAD 03-27-2025
- ALLR 03-07-2025
- Dividend Yield
- CEAD N/A
- ALLR N/A
- EPS Growth
- CEAD N/A
- ALLR N/A
- EPS
- CEAD N/A
- ALLR N/A
- Revenue
- CEAD N/A
- ALLR N/A
- Revenue This Year
- CEAD N/A
- ALLR N/A
- Revenue Next Year
- CEAD N/A
- ALLR N/A
- P/E Ratio
- CEAD N/A
- ALLR N/A
- Revenue Growth
- CEAD N/A
- ALLR N/A
- 52 Week Low
- CEAD $5.60
- ALLR $0.90
- 52 Week High
- CEAD $11.04
- ALLR $283.20
- Technical
- Relative Strength Index (RSI)
- CEAD 43.05
- ALLR 47.17
- Support Level
- CEAD $7.21
- ALLR $0.98
- Resistance Level
- CEAD $7.80
- ALLR $1.99
- Average True Range (ATR)
- CEAD 0.23
- ALLR 0.21
- MACD
- CEAD -0.06
- ALLR 0.00
- Stochastic Oscillator
- CEAD 9.81
- ALLR 15.45
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.